Navigation Links
Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Financial Guidance
Date:3/15/2013

ces will be sufficient to fund projected operating requirements into the fourth quarter of 2013. In order to meet its cash requirements beyond the fourth quarter of 2013, the company would have to raise additional funds through corporate partnering or additional financing.  There is no assurance Telik will be successful in obtaining additional funding in the near future to fund registration trial or continue its operations.

About Telik

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer. The company's most advanced drug candidate is Telintra®, a modified glutathione analog intended for the treatment of hematologic disorders including myelodysplastic syndrome; followed by Telcyta®, a cancer activated prodrug for the treatment of a variety of cancers. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small molecule drug candidates.  Additional information is available at www.telik.com.

Forward Looking Statements

This press release contains "forward looking" statements, including statements regarding Telik's financial outlook and expected cash utilization for 2013 and the future development of TELINTRA, preclinical drug candidates and potential corporate partnerships. These forward looking statements are based upon Telik's current expectations. There are important factors that could cause Telik's results to differ materially from those indicated by these forward-looking statements, including, among others, that Telik would be unable to continue to fund its operations if it is unable to  raise adequate funding; if the development of its drug candidates, including clinical trials of TELINTRA, is delayed or unsuccessful, if Telik does not enter into collaborat
'/>"/>

SOURCE Telik, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Telik Announces Third Quarter 2012 Financial Results
2. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
3. ULURU Inc. Announces Closing Of $440,000 Private Placement
4. Cardica Announces Proposed Public Offering of Common Stock
5. PAREXEL International Provides Update On Share Repurchase Program, Announces A New $50 Million Accelerated Share Repurchase Agreement And A New $50 Million 10b5-1 Trading Plan
6. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
7. Simbionix Announces License Agreement for Surgical Videos
8. BioTrends Announces the Continuation of a Syndicated Report Series: TreatmentTrends: CKD Stages 1-5ND
9. Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
10. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
11. PDI, Inc. Announces $17 Million Multi-Year Sales Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015   KaloBios Pharmaceuticals, Inc ... focused on developing innovative therapies to benefit patients with ... oncology, announced today that the U.S. Food and Drug ... (IND) application for KB003, an anti-GM-CSF monoclonal antibody (mAb), ... the IND is now active. The acceptance ...
(Date:7/29/2015)... 29, 2015  The Perinatal Quality Foundation (PQF) ... of the advantages, limitations and clinically appropriate interpretation ... diagnostic tests for pregnant women and their healthcare ... world,s leading provider of diagnostic information services, is ... through a grant. Through a ...
(Date:7/29/2015)... LabStyle Innovations Corp. (DRIO), today announced that its Dario™ Diabetes ... in Australia .  The Dario was recently ... reimbursement approval in that country. 9 News ... diabetes. As a case in point, the news segment presented ... year old boy with Type 1 diabetes and his mother. ...
Breaking Medicine Technology:KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 2Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 3Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 4LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 3
(Date:7/29/2015)... BC (PRWEB) , ... July 29, 2015 , ... Angelo’s ... of its new service: water damage restoration of carpets and rugs. The company will ... well as for commercial clients. , An overflowing overhead tank, rain leaking through ...
(Date:7/29/2015)... ... 2015 , ... The healthcare analytics market is categorized on ... such as the rising pressure to curb healthcare costs, big data in healthcare, ... investments are driving market growth. Check 149 data tables & 57 figures spread ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... are anticipating testing regulations imposed by the FDA for nicotine laced liquid products. ... of electronic cigarettes have raised considerably. E-Cigarettes are particularly troublesome to addiction professionals ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Orthopedic surgeons ... now offer the Rotation Medical Rotator Cuff System, a new implant to treat a ... is designed to foster natural regeneration of additional tendon tissue, which could allow for ...
(Date:7/29/2015)... ... July 29, 2015 , ... CanAm Enterprises, LLC (“CanAm”) is thrilled to announce ... I-829 approvals have been granted to investors in four different CanAm EB-5 projects -- ... project in Philadelphia, and the Valley Forge Convention Center project in CanAm’s regional center ...
Breaking Medicine News(10 mins):Health News:Angelo’s FabriClean Now Offers Water Damage Restoration For Residential and Commercial Accounts 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 3Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 4Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 5Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3
... forced to use ,workarounds, to ensure medication errors are kept ... News) -- Flaws in the design and implementation of barcode ... of the right medication can increase the risk of certain ... use of the system in five U.S. hospitals. , ...
... Make Cashless Visits To Seven Star Medica Hospitals, ... health and,safety services company, announced today that it has ... to its seven facilities in,Mexico. HTH Worldwide will now ... Medica facility for those who carry HTH insurance. Star,Medica,s ...
... Pa., July 3 Vibra Healthcare, LLC,("Vibra") announced ... two,specialty hospitals in Southern California. The acquisition included ... freestanding,Long Term Acute Care Hospital -- LTACH) and ... CA (a 60-bed freestanding Acute,Rehabilitation Hospital)., Brad ...
... air pollution,resulting from wildfires poses lethal health hazards ... Residents with respiratory problems such,as asthma, emphysema, and ... take extra precautions during this time and call ... without lung diseases are at risk during this ...
... older drugs as good as newer ones, study ... -- Taking prescription medications can help reduce violent ... , It included 1,445 schizophrenia patients randomly selected ... perphenanize, quetiapine, risperidone or ziprasidone. , Patient violence ...
... Ill., July 3 Hong Ray Enterprises of,Shijiazhuang, China, ... major manufacturer of nitrile gloves, has notified Medline,Industries, Inc., ... conditions" and that they will be unable to meet ... exam glove supplier., "This disruption to supply will ...
Cached Medicine News:Health News:Barcode Technology Flaws Put Some Patients at Risk 2Health News:HTH Worldwide Signs Agreement with Star Medica to Give Travelers to Mexico Top Hospital Care 2Health News:American Lung Association Urges People Living Near Wildfires to Protect Themselves Against Staggering Levels of Unhealthy Air Pollution 2Health News:American Lung Association Urges People Living Near Wildfires to Protect Themselves Against Staggering Levels of Unhealthy Air Pollution 3Health News:Medication Reduces Violence in Some Schizophrenics 2Health News:Medline Receives Force Majeure Notice From Hong Ray Enterprises 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: